References
- Bohn H. Isolierung und Characterisierung des schwangerschafts-spezifischen β1-glycoproteins. Blut 1972; 24: 292–302
- Bohn H. Untersuchungen uber das schwanger-schafts-spezifische β1 Glykoprotein (SP1). Arch Gynäk 1974; 216: 347–58
- Heikinheimo M, Wahlström T, Lehto V-P, Stenman U-H. Evidence for the presence of oncoplacental SP1-like protein in normal nonpregnant serum. J Clin Endocrinol Metab 1985; 61: 188–91
- Tatarinov YuS, Sokolov A V. Development of a radioimmunoassay for pregnancy-specific beta1-globulin and its measurement in serum of patients with trophoblastic and non-trophoblastic tumours. Int J Cancer 1977; 19: 161–6
- Tatra G, Breitenecker G, Gruber W. Serum concentration of pregnancy-specific β-1 -glycoprotein (SP-1) in normal and pathologic pregnancies. Arch Gynäk 1974; 217: 383–90
- Gordon Y B, Grudzinskas J G, Jeffrey D, Chard T. Concentrations of pregnancy-specific β1-glycoprotein in maternal blood in normal pregnancy and in intrauterine growth retardation. Lancet 1977; i: 331–3
- Heikinheimo M, Jalanko H, Leisti J, Kolho K-L, Salonen R, von Koskull H, Aula P. Amniotic fluid pregnancy-specific β1-glycoprotein (SPI) in fetal developmental disorders. Prenat Diagn 1984; 4: 147–50
- Bartels I, Lindemann A. Maternal levels of pregnancy-specific β1-glycoprotein (SP-1) are elevated in pregnancies affected by Down's syndrome. Hum Gen 1988; 80: 46–8
- Grudzinskas J G, Gordon Y B, Jeffrey D, Chard T. Specific and sensitive determination of pregnancy-specific β1-glycoprotein by radioimmunoassay. Lancet 1977; i: 333–5
- Kaminska J, Calvert I, Rosen S W. Radioimmunoassay of 'pregnancy-specific'-β1-glycoprotein (SP1. Clin Chem 1979; 25: 577–80
- Bruce D, Klopper A. The measurement of pregnancy specific β1-glycoprotein by electroimmuno-diffusion. Clin Chim Acta 1978; 84: 107–13
- Wood P J, Cockett D, Mason P. A rapid and inexpensive laser nephelometric assay for plasma pregnancy specific β1-glycoprotein levels. Clin Chim Acta 1978; 90: 87–91
- Spencer K, Price C P, Anthony F, Wood P J. Kinetic immunoturbidimetry: the measurement of pregnancy specific β1 glycoprotein. Clin Chim Acta 1979; 99: 177–87
- Macdonald D J, Belfield A, Steele C J, Mack D S, Shah M M. The quantitation of pregnancy specific β1-glycoprotein by enzyme-linked immunoassay. Clin Chim Acta 1979; 94: 41–9
- Feldmann U, Schneider B, Klinkers H, Haeckel R. A multivariate approach for the biometric comparison of analytical methods in clinical chemistry. J Clin Chem Clin Biochem 1981; 19: 121–37
- Wurz H, Geiger W, Kunzig H J, Jabs-Lehman A, Bohn H, Luben G. Radioimmunoassay of SP1 (pregnancy-specific β1 -glycoprotein) in maternal blood and in amniotic fluid in normal and pathological pregnancies. J Perinat Med 1981; 9: 67–78
- Pala A, DiRuzza A, Curtilli L, Strom R, Moro M, Reverberi L, Carenza L. Interference of an α2 component in immunological determinations of pregnancy-specific β1 glycoprotein in serum. Clin Chim Acta 1987; 168: 33–46
- Heller G, Linneke P, Voss P, Jeske W. Referenz-bereiche von α-Fetoprotein (AFP) und schwan-gerschaftsspezifischem β1-Glykoprotein (SP1) in der Fruhschwangerschaft. Zentbl Gynakol 1988; 110: 1556–60
- Teisner B, Westergaard J G, Folkersen J, Husby S, Svehag S E. Two pregnancy-associated serum proteins with pregnancy-specific β1-glycoprotein determinants. Am J Obstet Gynecol 1978; 131: 262–6
- Teisner B, Grudzinskas J G, Hindersson P, Al-Ani A TM, Westergaard J G, Chard T. Molecular heterogeneity of pregnancy specific β1 glycoprotein: the effect on measurement by radioimmunoassay and electroimmunoassay. J Immunol Meth 1979; 31: 141–9
- Anthony F, Spencer K, Mason P, Masson G M, Price C P, Wood P J. The variable influence of an a component in pregnancy plasma on four different assay systems for the measurement of pregnancy-specific β1 glycoprotein. Clin Chim Acta 1980; 105: 287–95